Insider Trading & Ownership - KOCH KEVIN

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for KOCH KEVIN
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-03-07
Sale
2025-03-11
4:32 pm
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
100 $30 $3,000 394,807
(Indirect
Direct)
View
2025-02-05
Sale
2025-02-07
4:38 pm
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
9,536 $30.13 $287,316 437,452
(Indirect
Direct)
View
2024-05-02
Sale
2024-05-03
6:26 pm
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
3,152 $18.91 $59,604 363,679
(Indirect
Direct)
View
2023-05-02
Sale
2023-05-03
6:25 pm
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
3,203 $8.9049 $28,522 366,831
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-03-07
Exercise
2025-03-11
4:32 pm
N/A
N/A
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
100 $0.18 394,807
(Direct)
View
2025-03-07
Exercise
2025-03-11
4:32 pm
2021-06-13
2027-08-08
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
100 $0 394,807
(Direct)
View
2025-02-05
Exercise
2025-02-07
4:38 pm
N/A
N/A
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
8,636 $0.18 437,452
(Direct)
View
2025-02-06
Exercise
2025-02-07
4:38 pm
N/A
N/A
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
900 $13.11 437,452
(Direct)
View
2025-02-05
Exercise
2025-02-07
4:38 pm
2021-06-13
2027-08-08
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
9,536 $0 437,452
(Direct)
View
2024-08-12
Option Award
2024-08-14
4:14 pm
N/A
2034-08-12
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
503,125 $0 503,125
(Direct)
View
2024-05-01
Exercise
2024-05-03
6:26 pm
N/A
2032-05-01
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
10,417 $0 363,679
(Direct)
View
2023-08-17
Option Award
2023-08-18
7:12 pm
N/A
2033-08-17
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
600,000 $0 600,000
(Direct)
View
2023-05-01
Exercise
2023-05-03
6:25 pm
N/A
2032-05-01
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
10,416 $0 366,831
(Direct)
View
2022-08-08
Option Award
2022-08-10
5:41 pm
N/A
2032-08-08
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
550,000 $0 550,000
(Direct)
View
2022-05-01
Option Award
2022-05-03
4:14 pm
N/A
2025-05-01
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
31,250 $0 31,250
(Direct)
View
2021-08-17
Option Award
2021-08-19
5:09 pm
N/A
2031-08-17
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
400,000 $0 400,000
(Direct)
View

Ownership
2021-03-25
9:38 pm
N/A
N/A
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
President and CEO
0 $0 2,105,104
(Indirect)
View
2020-05-21
Option Award
2020-05-22
5:16 pm
N/A
2030-05-20
MIRAGEN THERAPEUTICS INC. MGEN KOCH KEVIN
Director
24,000 $0 24,000
(Direct)
View